System and Method for Estimating Perfusion Parameters Using Medical Imaging
US-2019150764-A1 · May 23, 2019 · US
US2024201296A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2024201296-A1 |
| Application number | US-202318481551-A |
| Country | US |
| Kind code | A1 |
| Filing date | Oct 5, 2023 |
| Priority date | Apr 16, 2021 |
| Publication date | Jun 20, 2024 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Methods for performing frequency and phase correction of magnetic resonance spectroscopy (MRS) data in quantifying one or more metabolites involved in the pathology of schizophrenia and related disorders.
Opening claim text (preview).
1 . A method for performing frequency and phase correction of magnetic resonance spectroscopy (MRS) data to quantify one or more metabolites, the method comprising: receiving spectrum data related to a plurality of metabolites generated using magnetic resonance spectroscopy of a subject's brain; generating corrected on-spectrum data and corrected off-spectrum data by inputting the received spectrum data to a trained machine learning model, wherein the trained machine learning model estimates frequency corrections and phase corrections for the input spectrum data; and quantifying one or more of the metabolites according to the corrected on-spectrum data and corrected off-spectrum data. 2 . The method of claim 1 , wherein the trained machine learning model comprises a convolutional neural network with a plurality of convolutional layers. 3 . The method of claim 1 , wherein the trained machine learning model comprises a dual stream convolutional neural network. 4 . The method of claim 3 , wherein the dual stream convolutional neural network comprises a first stream for frequency correction and a second stream for phase correction. 5 . The method of claim 4 , wherein the first stream comprises a plurality of convolutional layers and the second stream comprises a plurality of convolutional layers. 6 . The method of claim 4 , wherein the first stream comprises a same architecture as the second stream. 7 . The method of claim 4 , wherein input to the first stream comprises magnitude spectrum data and input to the second stream comprises real spectrum data. 8 . The method of claim 1 , wherein the trained machine learning model comprises a transformer network with a plurality of multi-head attention blocks. 9 . The method of claim 8 , wherein the trained machine learning model comprises an encoder comprising a multi-head attention block and a decoder comprising at least two multi-head attention blocks. 10 . The method of claim 1 , wherein the received spectrum data comprises on-spectrum data and off-spectrum data. 11 . The method of claim 10 , wherein generating the corrected on-spectrum data and the corrected off-spectrum comprises: applying the estimated frequency corrections to the received on-spectrum data and the received off-spectrum data; and applying the estimated phase corrections to the received on-spectrum data and the received off-spectrum data. 12 . The method of claim 11 , wherein the estimated frequency corrections are applied to the received on-spectrum data and the received off-spectrum data, and the estimated phase corrections are applied to the on-spectrum data and the off-spectrum data with the applied frequency corrections. 13 . The method of claim 1 , wherein the received spectrum data comprises single voxel MEGA-PRESS MRS data. 14 . The method of claim 1 , wherein the quantified metabolite is quantified over at least a portion of the subject's brain. 15 . The method of claim 1 , wherein the quantified metabolite comprises GABA. 16 . The method of claim 1 , wherein the quantified metabolite comprises glutamate or glutamine. 17 . The method of claim 16 , wherein a therapeutic agent is administered to the subject based on the quantified glutamate or glutamine, wherein the therapeutic agent reduces, decreases or inhibit glutamate or glutamine. 18 . The method of claim 1 , wherein quantifying one or more of the metabolites according to the corrected on-spectrum data and corrected off-spectrum data comprises calculating a difference between the off-spectrum data and the on-spectrum data. 19 . A system for performing frequency and phase correction of magnetic resonance spectroscopy (MRS) data to quantify one or more metabolites, the system comprising: a processor; and a memory storing instructions for execution by the processor, the instructions configuring the processor to: receive spectrum data related to a plurality of metabolites generated using magnetic resonance spectroscopy of a subject's brain; generate corrected on-spectrum data and corrected off-spectrum data by inputting the received spectrum data to a trained machine learning model, wherein the trained machine learning model estimates frequency corrections and phase corrections for the input spectrum data; and quantify one or more of the metabolites according to the corrected on-spectrum data and corrected off-spectrum data. 20 . (canceled) 21 . A non-transitory computer readable medium having instructions stored thereon that, when executed by a processor, cause the processor to perform frequency and phase correction of magnetic resonance spectroscopy (MRS) data to quantify one or more metabolites, wherein, when executed, the instructions cause the processor to: receive spectrum data related to a plurality of metabolites generated using magnetic resonance spectroscopy of a subject's brain; generate corrected on-spectrum data and corrected off-spectrum data by inputting the received spectrum data to a trained machine learning model, wherein the trained machine learning model estimates frequency corrections and phase corrections for the input spectrum data; and quantify one or more of the metabolites according to the corrected on-spectrum data and corrected off-spectrum data. 22 - 23 . (canceled)
Data processing and visualization specially adapted for MR, e.g. for feature analysis and pattern recognition on the basis of measured MR data, segmentation of measured MR data, edge contour detection on the basis of measured MR data, for enhancing measured MR data in terms of signal-to-noise ratio by means of noise filtering or apodization, for enhancing measured MR data in terms of resolution by means for deblurring, windowing, zero filling, or generation of gray-scaled images, colour-coded images or images displaying vectors instead of pixels (image data processing or generation, in general G06T) · CPC title
based on chemical shift information {[CSI] or spectroscopic imaging, e.g. to acquire the spatial distributions of metabolites} · CPC title
Processing of acquired signals, e.g. elimination of phase errors, baseline fitting, chemometric analysis · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.